Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,610 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Use Lenalidomide (Revlimid®) in Combination With Dexamethasone in Clinical Practice for the Treatment of Newly Diagnosed Multiple Myeloma (MM) Transplant Ineligible Patients

NCT03001804

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Landeskrankenhaus Kirchdorf Kirchdorf, Austria
  • Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria
  • Kepleruniversitätsklinikum GmbH, Hämatologie und Internistische Onkologie Linz, Austria
  • Ordensklinikum Linz GmbH Elisabethinen Linz, Austria
View Trial Details
Completed

agenT-797 in Participants With Relapsed/Refractory Multiple Myeloma

NCT04754100

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Norton Cancer Institute - St. Matthews - Medical Oncology/Hematology Candida Louisville, Kentucky, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Cincinnati Cancer Center Cincinnati, Ohio, United States
View Trial Details
Completed

Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT01734928

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Southern Cancer Center Mobile, Alabama, United States
  • Arizona Oncology Tucson, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
View all 321 locations
View Trial Details
Completed

Corneal Toxicity in Patients Treated by Belantamab Mafodotin

NCT05887206

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • CHU Dijon Dijon, France
  • CHU de Limoges - Hôpital Dupuytren Limoges, France
  • HCL- Croix Rousse Lyon, France
  • Clinique Monticelli-Vélodrome Marseille, France
View Trial Details
Completed

High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment

NCT03234335

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +20 more
Locations
  • Centre Pierre et Marie Curie Algiers, Algeria
  • EHU Oran Oran, Algeria
  • CHU Sart Tilman Liège, Belgium
  • Centre Hospitalier Universitaire d'Amiens Amiens, France
View all 33 locations
View Trial Details

Related conditions